CommentaryIs topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?☆
References (33)
- et al.
TPM protects against glutamate- and kainate-induced neurotoxicity in primary neuronal–astroglial cultures
Epilepsy Res.
(2003) - et al.
Pathobiology of ischemic stroke; an integrated view
Trends Neurosci.
(1999) - et al.
TPM as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration
Life Sci.
(2001) - et al.
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Neuropharmacology
(2004) - et al.
Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils
Neurosci. Lett.
(2000) The possible contribution of microglia and macrophages to delayed neuronal death after ischemia
J. Neurol. Sci.
(1993)- et al.
Antioxidant strategies in the treatment of stroke
Free Radical Biol. Med.
(2005) - et al.
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
Neuron
(1994) - et al.
Neuroprotective effects of topiramate after hypoxia–ischemia in newborn piglets
Brain Res.
(2005) - et al.
Topiramate prevents excitotoxic damage in the newborn rodent brain
Neurobiol. Dis.
(2005)
Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold
Epilepsy Res.
Neuroprotection by delayed administration of TPM in a rat model of middle cerebral artery embolization
Brain Res.
Topiramate reduces excitotoxic and ischemic injury in the rat retina
Brain Res.
Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells
Neurosci. Lett.
Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures
J. Neurochem.
Topiramate: a new potential pharmacological treatment for obesity
Obes. Res.
Cited by (14)
Pathophysiology
2018, Volpe's Neurology of the NewbornPotential neuroprotective effects of continuous topiramate therapy in the developing brain
2011, Epilepsy and BehaviorCitation Excerpt :Importantly, these are two very different measures, yet they both indicate that activity levels are disturbed in these mice, including those who underwent intraperitoneal injections and those who did not. Protective effects of short-term TPM therapy have been demonstrated in many models of neuronal injury such as pilocarpine-induced status epilepticus (SE), flurothyl-induced SE, hypoxia/ischemia, retinal ischemia, stroke, and limbic SE induced by electrical stimulation [23–30]. Our study extends these observations to include chronic TPM therapy in the P10 hypoxia model.
Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: A safety study
2010, Journal of PediatricsNeuroprotection in Infant Heart Surgery
2008, Clinics in PerinatologyCitation Excerpt :Still, the observation that the nearly 20% PVL in preoperative MRIs increases to more than 50% postoperatively suggests that this may still be the most fruitful time period to attempt intervention. Topiramate is an attractive candidate for pharmacologic neuroprotection in the infant heart surgery population.55 It is an orally available anti-seizure medication that was approved by the US Food and Drug Administration to treat seizure disorders in the United States in 1996.
Pharmacotherapy and motor recovery after stroke
2018, Expert Review of NeurotherapeuticsPathophysiology: General Principles. General Principles.
2017, Volpe's Neurology of the Newborn
- ☆
Commentary on: Noh et al.'s “Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats”.